No Data
No Data
Sharps Technology Clinches Major Syringe Supply Deal With Stericare
Sharps Technology Enters Into 5-Year Sales Agreement With Strategic U.S. Medical Products Company Creating +$50M In New Revenue For EU Facility, Definitive Agreement Sells Out The 10mL SoloGard Production Capacity At Sharps' Manufacturing Site
Express News | Sharps Technology Enters Into a Five-Year Sales Agreement With Strategic U.S. Medical Products Company Creating +$5O Million in New Revenue for EU Facility
Sharps Technology: Securities Will Be Delisted Unless Company Requests Hearing and Appeals Nasdaq's Determination by July 16
Sharps Technology: Pursuant to Nasdaq Letter July 9, Company Hasn't Regained Compliance With Listing Rule
Sharps Technology Announces Crucial Financial Update
No Data